Kenvue Inc. (KVUE) Cash Flow Statement

The wide quarterly swings in OCF/NI—from 0.65 to 2.59—reflect the lumpy nature of working capital changes, particularly in trade receivables and payables. While the cumulative OCF over the ten quarters ($5.14B) exceeds cumulative net income ($3.43B), the inconsistency implies that earnings quality is not uniformly high. Investors should monitor whether the negative working capital contributions in recent quarters (e.g., -$203M in Q1 2026) indicate a structural shift or merely seasonal timing.

The FCF margin expansion is encouraging, but the volatility—driven by swings in working capital and capex timing—means the trend is not yet smooth. The Q2 2026 FCF of $827M was boosted by a $203M positive working capital contribution, while Q1 2026 saw a $203M drag. This pattern suggests that management is actively managing cash conversion, but the underlying business may still be adjusting to standalone operations. The cumulative FCF of $4.23B over ten quarters is solid, but the uneven path warrants caution.

The low average capex intensity is typical for a consumer staples company, but the Q4 2025 spike is notable. If this represents a one-time investment in automation or capacity, it could signal a strategic pivot. However, the subsequent quarters show capex returning to ~3.5% of revenue, suggesting the spike was an anomaly. The depreciation run-rate of ~$140M per quarter is roughly in line with capex, implying that current spending is just maintaining the asset base. Investors should watch whether management increases capex to support innovation in Skin Health, which could pressure near-term FCF.

The erratic working capital changes are a key source of cash flow volatility. The negative contributions in early 2024 (e.g., -$339M in Q1 2024) likely reflect destocking by retailers, while the positive swings in late 2025 and 2026 may indicate a reversal. This suggests that Kenvue's cash flow is sensitive to retailer inventory cycles, which can obscure underlying demand. The company's ability to manage payables and receivables will be critical to smoothing cash flow, but the data shows no clear trend, warranting close monitoring.

The steady dividend payout, despite volatile FCF, indicates a commitment to shareholder returns. However, the cessation of buybacks after Q4 2025—when $70M was repurchased—may signal a strategic pause, possibly to preserve cash for debt reduction or potential M&A. The dividend payout ratio, based on cumulative net income of $3.43B, exceeds 100%, which is unsustainable unless FCF remains robust. This suggests that management is prioritizing dividend stability, but investors should monitor whether this constrains future growth investments.

The cumulative OCF/NI ratio of 1.50 indicates that cash generation has been stronger than reported earnings, which is a positive signal for earnings quality. However, this gap is partly due to large non-cash items like D&A and SBC, which totaled $1.4B and $0.39B, respectively. As the company moves past the spin-off, the gap may narrow, but the current divergence suggests that reported earnings understate the company's cash-generating ability. Investors should watch whether this trend persists, as it could indicate conservative accounting or one-time benefits.